Centrus Energy (LEU) is back in focus after a series of announcements regarding its role as the only U.S. Nuclear Regulatory Commission licensed producer of high assay low enriched uranium, as well as a multibillion dollar capacity expansion.

Those announcements and contracts have landed during a volatile stretch, with the share price at US$210.63 after a 1-day share price return of 1.67% and a 30-day share price return decline of 25.23%. The 1-year total shareholder return of 125.27% and the very large 5-year total shareholder return suggest powerful long term momentum that recent pullbacks have only partly cooled.

If Centrus Energy has you thinking about how nuclear-related names are trading, it could be worth checking out our 84 nuclear energy infrastructure stocks as another way to find ideas tied to the same theme.

With revenues at US$448.7 million, net income of US$77.8 million and a share price sitting below the average analyst target, the real question is whether Centrus is still undervalued or if the market is already pricing in its prospects.

Most Popular Narrative: 24.7% Undervalued

Against the narrative fair value of $279.73, Centrus Energy closing at $210.63 leaves a sizeable gap that hinges on how its growth and funding story plays out.

The current valuation assumes Centrus will rapidly scale capacity to meet rising demand just as Russian supply exits the Western market. However, timelines for building new cascades are long (the first cascade takes 42 months and subsequent cascades take months each) and are highly dependent on the allocation and timing of DOE funding. Any holdup in these government awards or in private capital inflows could lead to prolonged periods of underutilized cash, lower revenue, and diminished operating leverage, which could in turn pressure future margins and earnings.

Want to understand why this valuation leans so heavily on future execution and funding? Revenue scaling, margin compression and a rich future earnings multiple are central to this story. Curious how these ingredients combine to support that fair value, even as forecasts build in lower profitability over time? The full narrative lays out the numbers behind those assumptions.

Result: Fair Value of $279.73 (UNDERVALUED)

However, those assumptions could unravel if Department of Energy funding is slower than expected or if nuclear demand softens as alternative energy technologies gain more traction.

Another View: Rich P/E Raises a Flag

That 24.7% gap to the narrative fair value suggests room for upside, but the current P/E of 53.2x tells a different story. It sits well above both the peer average of 18.1x and a fair ratio of 13.2x, which points to meaningful valuation risk if sentiment cools.

Our P/E based view also shows Centrus trading richer than the broader US Oil and Gas industry at 14.1x. If the market gravitates closer to that fair ratio over time, today’s pricing could feel tight rather than cheap. The key question is whether you think the premium is durable.

Next Steps

If this mix of potential and risk feels finely balanced, it could be worth acting now and testing the assumptions against the data yourself with 3 key rewards and 3 important warning signs.

Looking for more investment ideas?

If Centrus has sharpened your focus on opportunities, do not stop here. Use the Simply Wall St Screener to line up your next potential moves with intent.

• Target potential mispricings by scanning a curated set of 53 high quality undervalued stocks that pair solid fundamentals with appealing valuations.
• Prioritize resilience by reviewing 80 resilient stocks with low risk scores, so you do not miss companies that score well on stability when sentiment shifts.
• Hunt for underfollowed potential by checking our screener containing 23 high quality undiscovered gems, where quieter names with quality metrics may still fly under the radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.